decisionhealth Newsletters, Coder Pink Sheets - 2008 Issue 9 (September)
No NCD on DNA stool test
Subscribe or sign in to view the full article.
Article Overview
This brief news item explains that CMS did not extend Medicare colorectal cancer screening coverage to include a commercially available stool DNA test at the time discussed. It also notes the FDA’s position, the CMS transmittal cited by the article, and the possibility of future reconsideration after regulatory approval. The piece is relevant to coding, reimbursement, and compliance professionals who follow Medicare preventive service coverage updates.
Why This Topic Matters
Coverage policy changes can affect whether a service is payable under Medicare and how providers, billers, and compliance teams interpret screening benefits. This article helps readers track a federal coverage decision and the agencies involved.
What You Will Learn
- How CMS approached a proposed colorectal cancer screening coverage expansion
- What federal agency concerns were cited in the coverage discussion
- Why the article points readers to a Medicare transmittal for the official update
- What type of future reconsideration was mentioned in the coverage context
Who Should Read This
- Medical coders
- Billing staff
- Compliance professionals
- Revenue cycle teams
- Healthcare administrators
- Gastroenterology practices
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com